🏀 March Madness Special 🏀 20% Off Every Order in March 🏀 No code needed — applied at checkout! 🏀
BPC-157, TB-500, GHK-Cu & Tissue Repair Peptides
The most comprehensive research collection on recovery and healing peptides — covering BPC-157, TB-500, GHK-Cu, and combination protocols for tendon, ligament, gut, cardiovascular, and wound healing research.
Lead Compounds
BPC-157, TB-500, GHK-Cu
Primary Research Area
Tissue Repair & Healing
Mechanism
Growth factor & VEGF upregulation
Research Articles
21+ peer-reviewed overviews
A comprehensive overview of BPC-157, a synthetic pentadecapeptide, focusing on its molecular characteristics, research findings, mechanisms of action, and potential applications in tissue repair and angiogenesis studies.
GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is a naturally occurring human plasma tripeptide with a high affinity for copper ions. Decades of research have implicated it in wound healing, collagen synthesis, anti-inflammatory signaling, and gene expression regulation, making it one of the most studied naturally derived peptides in regenerative medicine research.
TB-500 is a synthetic version of the 43-amino acid peptide Thymosin Beta-4 (Tbeta4), one of the most abundant intracellular peptides in mammalian cells. Research has identified roles in actin dynamics, cell migration, wound healing, angiogenesis, and cardiac repair, making TB-500 a subject of significant interest in regenerative medicine research.
The BPC-157/TB-500 combination pairs two of the most studied regenerative peptides in preclinical research. BPC-157 targets angiogenesis and tendon-to-bone healing through growth factor upregulation, while TB-500 promotes cell migration and actin dynamics. Together, they address complementary aspects of the tissue repair cascade.
A detailed review of the dosing parameters used in published BPC-157 animal studies, including effective dose ranges, administration routes, and study duration reported in peer-reviewed literature.
A review of dosing parameters, administration routes, and study designs used in published Thymosin Beta-4 (TB-500) preclinical research, drawn from peer-reviewed literature.
A side-by-side comparison of BPC-157 and TB-500 (Thymosin Beta-4 fragment) based on published preclinical research, examining their distinct mechanisms of action, tissue targets, and research applications.
A review of the peptides most extensively studied in preclinical tissue recovery and repair models, summarizing the published evidence for each compound's research applications.
An examination of the scientific rationale for combining BPC-157 and TB-500 in tissue repair research, reviewing their complementary mechanisms and the available published evidence on combined administration.
A review of GHK-Cu (copper peptide) and NAD+ as research tools in cellular repair and aging models, examining their distinct mechanisms and the published evidence for each compound.
An examination of BPC-157's documented interactions with enteric nervous system pathways and central nervous system modulation in preclinical studies.
A detailed look at how TB-500's thymosin beta-4 sequence interacts with G-actin to promote cell migration, angiogenesis, and tissue repair in preclinical models.
A review of GHK-Cu's copper-binding chemistry, collagen synthesis stimulation, and antioxidant properties documented in published preclinical and clinical research.
A side-by-side comparison of BPC-157 and TB-500 research: mechanisms, tissue targets, published evidence, and the rationale for studying them in combination.
A mechanistic analysis of the BPC-157, TB-500, and GHK-Cu combination for tissue repair research, examining how the three compounds target complementary biological pathways.
A mechanistic review of the Epithalon, GHK-Cu, and NAD+ combination for anti-aging research, examining how each compound targets distinct hallmarks of cellular aging.
A review of BPC-157's documented effects on nitric oxide production and eNOS activation, and the implications for vascular and tissue repair research.
A comparison of GHK-Cu and Epidermal Growth Factor (EGF) as skin repair research compounds, examining their distinct mechanisms and the evidence for each in wound healing and skin rejuvenation research.
A review of the molecular pathways governing collagen synthesis in fibroblasts and how research peptides including GHK-Cu, BPC-157, and TB-500 interact with these pathways.
A review of angiogenesis biology and how research peptides including BPC-157, TB-500, and GHK-Cu promote new blood vessel formation through VEGF and related pathways.
An in-depth look at GHK-Cu (glycyl-L-histidyl-L-lysine copper complex), examining its role in collagen synthesis, wound healing, skin biology, and anti-inflammatory signaling based on published preclinical and clinical research.
A research overview of KPV (Lys-Pro-Val), a melanocortin-derived tripeptide with potent anti-inflammatory properties, examining its PepT1-mediated intestinal uptake mechanism and research applications in inflammatory bowel disease and gut biology models.
An examination of the research rationale for combining BPC-157 and TB-500 (Thymosin Beta-4) in experimental models, exploring their complementary mechanisms in tissue repair, angiogenesis, and inflammation modulation.
A research-focused review of the CJC-1295 and Ipamorelin combination, examining how simultaneous activation of GHRH receptors and ghrelin receptors produces synergistic growth hormone secretion in experimental models.
An exploration of the research rationale for studying GHK-Cu (copper tripeptide) alongside NAD+ precursors, examining their complementary roles in cellular repair, mitochondrial function, and epigenetic regulation in experimental models.
A research overview examining the complementary mechanisms of Epithalon (Epitalon), a telomerase-activating tetrapeptide, and NAD+ precursors in the context of cellular aging, telomere maintenance, and mitochondrial health research.
A research overview of Semax and Selank, two synthetic neuropeptides developed in Russia, examining their distinct yet complementary mechanisms in BDNF upregulation, anxiolytic activity, and cognitive function research in experimental models.
A comprehensive research overview of TB-500 (the synthetic fragment of thymosin beta-4), covering its role in actin regulation, angiogenesis, and tissue repair -- with a full review of preclinical evidence and the current state of clinical research.
GHK-Cu (copper tripeptide-1) is a naturally occurring plasma peptide that declines with age, stimulating collagen synthesis, wound healing, antioxidant defense, and gene expression remodeling — a complete research overview.
FOR RESEARCH PURPOSES ONLY — All content in this hub is intended strictly for scientific and educational reference. These compounds are not approved for human or animal consumption. Pure Pharm Peptides sells exclusively to qualified researchers.